Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q1 FY272026-07-31 | Q4 FY262026-04-24 | Q3 FY262026-01-23 | Q2 FY262025-10-24 | Q1 FY262025-07-25 | Q4 FY252025-04-25 | Q3 FY252025-01-24 | Q2 FY252024-10-25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.76B | $9.81B | $9.02B | $8.96B | $8.58B | $8.93B | $8.29B | $8.40B |
| Cost of revenue | $3.42B | $3.40B | $3.26B | $3.06B | $3.00B | $3.15B | $2.78B | $2.95B |
| Gross profit | $6.34B | $6.41B | $5.76B | $5.90B | $5.58B | $5.78B | $5.51B | $5.46B |
| Gross margin | 65.0% | 65.4% | 63.8% | 65.8% | 65.0% | 64.7% | 66.5% | 64.9% |
| Research and development | $771.00M | $671.00M | $722.00M | $754.00M | $726.00M | $684.00M | $675.00M | $697.00M |
| Selling, general and administrative | $3.20B | $3.06B | $2.96B | $2.97B | $2.81B | $2.72B | $2.72B | $2.76B |
| Operating expenses | $4.58B | $4.66B | $4.26B | $4.19B | $4.13B | $4.31B | $3.87B | $3.90B |
| Operating income | $1.76B | $1.75B | $1.50B | $1.71B | $1.44B | $1.47B | $1.64B | $1.56B |
| Operating margin | 18.1% | 17.8% | 16.6% | 19.1% | 16.8% | 16.5% | 19.8% | 18.6% |
| EBITDA | $2.57B | $2.69B | $2.32B | $2.46B | $2.26B | $2.78B | $2.37B | $2.27B |
| Interest expense | −$186.00M | −$176.00M | −$181.00M | −$181.00M | −$176.00M | −$174.00M | −$179.00M | −$209.00M |
| Income before taxes | $1.77B | $1.83B | $1.40B | $1.60B | $1.30B | $1.26B | $1.54B | $1.56B |
| Income taxes | $289.00M | $575.00M | $254.00M | $215.00M | $255.00M | $199.00M | $237.00M | $281.00M |
| Net income | $1.48B | $1.26B | $1.15B | $1.38B | $1.05B | $1.06B | $1.30B | $1.28B |
| Net margin | 15.2% | 12.8% | 12.7% | 15.4% | 12.2% | 11.9% | 15.7% | 15.2% |
| EPS, basic | $1.15 | $0.97 | $0.89 | $1.07 | $0.81 | $0.82 | $1.01 | $0.99 |
| EPS, diluted | $1.14 | $0.97 | $0.89 | $1.07 | $0.81 | $0.82 | $1.01 | $0.99 |
| Diluted shares | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B |
Figures describe Medtronic shares, not any token. As of Sep 3, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.